The Right Way to Return to Work.
For each of us. For all of us.

Protecting your business, your employees and your customers from COVID-19.

COVID-19 has impacted nearly every aspect of American life. It’s clear that both proactive screening and quick and reliable testing are going to be primary weapons to stop the spread, invaluable tools in bringing our businesses back to life, and a way to help us find The Right Way to Return to Work. RxGenomix is here to help every step of the way.

We provide screening and monitoring solutions, pooled (surveillance) testing, fast and reliable COVID-19/SARS CoV-2 testing, consultations with healthcare providers and advice on how to keep everyone around you safe and healthy. We can help you re-open your business safely and in a way your employees and customers will know you’re doing all you can for them.

Daily Monitoring and Point-of-Entry Screening

We’ll work with you to set a point-of-entry screening, monitoring and testing protocol, as well as a plan to communicate with your employees and customers. Learn more about screening and monitoring.


We will make sure the ordering, sample collection and shipping process is easy and safe.


Our partner laboratories will process the sample and return results as soon as possible. Learn more about testing options.


Our healthcare providers will discuss with each patient their results and the steps they should take to help stop the spread of infection.


We will report on the overall results of the program, tracking program adoption, compliance and aggregate test results.

Are you ready to return to work?

Contact us to get started today.

More Information

RxGenomix has partnered with accredited laboratories to order and provide diagnostic testing either approved by or authorized for use by the FDA*. Identifying who is actively carrying the virus that causes COVID-19 is going to be a critical step in treating the individual and limiting the spread of the disease. Results are available 36-48 hours after collection (with overnight shipping) and can be collected with a saliva collection device, a nasal swab or a nasopharyngeal swab.

* One method of sample collection utilizes a saliva collection device. This test has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. This test has not been FDA cleared or approved. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b) (1), unless the authorization is terminated or revoked sooner.

RxGenomix is now offering organizations the analytical and screening tools needed to successfully return to work onsite. We can provide an app that allows organizations to manage and monitor the return of employees, students, and volunteers by streamlining individual assessments, communication workflows, contact tracing, and population reporting. 

Users just take a quick survey from their computer or smart phone and a machine-learning engine recommends the best course of action for that day, based on federal, state, and organization specific guidelines. 

We have also added a point-of-entry screening solution that tracks vital stats for each person entering the building, tracking body temperature and keeping a record of their entry into the building, as well as keeping an overall population count for the facility.

As soon as they are identified for testing, each patient will receive clear guidance on steps they should take to limit the risk of infecting others, presuming they have been infected with the virus. Following each test, the patient will receive notification of their results in a timely fashion. All testing positive will be contacted by a healthcare provider for a virtual consultation where they will have a thorough opportunity to discuss with the healthcare provider a wide range of steps they should take to safeguard their own health and limit the risk of infecting others. They will also have the opportunity to ask any questions that concern them.

RxGenomix is actively monitoring current guidance from relevant regulatory agencies and can help advise you as to how employees may return to work safely and how you can protect the health of your customers while reopening your business. RxGenomix will work with you to communicate the testing program to your employees and educate guests and customers on every precaution you are taking to keep them safe and healthy. We will also support your internal efforts to educate and protect your employees for the long-term.

An antibody test looks for the presence of specific proteins made in response to infections. This can be helpful in determining who has already been exposed to the virus, and may be resistant to infection again. Antibodies can be found in the blood of people who are tested after infection and show that people have had an immune response to the infection. It typically takes 1 to 3 weeks after someone becomes infected with SARS-CoV-2 for their body to make antibodies (sometimes longer). The CDC is careful to point out that we don’t yet have a clear determination if the antibodies that result from SARS-CoV-2 infection will provide someone with immunity from a future infection, what level of antibodies it would take to provide that immunity, or how long the immunity would last.

Learn more about available testing options

Operating businesses safely and conducting some of the testing options we have available will require some personal protective equipment. From N95 masks and face shields to full coverall gowns, RxGenomix can get you what you need to stay in business and protected.

As new information becomes available, this page will be updated. Please check back or contact us with questions.